Glivec (imatinib) CML and GIST Treatment Glivec, CML, and GIST Treatment Information for International Healthcare Professionals Glivec, CML  and GIST Treatment Information for US Residents International Glivec Information from Novartis Oncology Click here to go to Novartis.com Novartis Oncology International Site
International Glivec Information from Novartis Oncology
Ask a question
Haematology and Oncology News from Glivec.com

Our weekly newsletter keeps you informed of the latest haematology and oncology news.

Help us improve Glivec.com.
Please take our short survey.

Print Glivec Information from Novartis Oncology emial
 

The following organisations feature extensive information about haematology, oncology, and cancer research in general.

AACR (American Association of Cancer Research)
http://www.aacr.org/

AA-MDSIF (Aplastic Anemia & MDS International Foundation)
http://www.aamds.org/aplastic

ASH (American Society of Hematology)
http://www.hematology.org/

ASHPO (American Society of Pediatric Hematology/Oncology)
http://www.aspho.org

ASCO (American Society of Clinical Oncology)
http://www.asco.org/

EBMT (European Group for Blood and Marrow Transplant)
http://www.ebmt.org/

EHA (European Haematology Association)
http://www.ehaweb.org/

ESMO (European Society for Medical Oncology)
http://www.esmo.org/

EORTC (European Organization for Research and Treatment)
http://www.eortc.be/

ISH (International Society of Hematology)
http://www.2007ish.org/paginasi/bienvenida.html

Novartis Oncology International Website
http://www.novartisoncology.com

Novartis Oncology US website
http://us.novartisoncology.com

 


Disclaimer: This is an international website for Glivec (imatinib) and is intended for healthcare professionals outside the US. If you are a US resident, please click on the For US Residents link at the top of this page. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.



Use of this website is subject to our Terms of Use.
© 2008 Novartis Pharma AG